Thrombotic thrombocytopenic purpura - Reduced activity of von Willebrand factor cleaving protease;Thrombotisch-thrombozytopenische purpura: Verminderte aktivität der von-Willebrand-faktor-spaltenden protease

Nervenarzt

Volumn 75, Issue 8, 2004, Pages 785-789

  Kunze, A ^a,b   Terborg, C ^a   Gerth, J ^a   Heide, G ^a   Witte, O W ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Neurological impairment; Platelet transfusion; Thrombotic thrombocytopenic purpura; Von Willebrand factor cleaving protease

Indexed keywords

LACTATE DEHYDROGENASE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; ANEMIA; ARTICLE; BLOOD FLOW VELOCITY; BRAIN ARTERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CONSCIOUSNESS DISORDER; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; ENZYME ACTIVITY; FEMALE; FEVER; HEADACHE; HUMAN; LABORATORY TEST; MICROANGIOPATHY; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGICAL ANATOMY; PERIPHERAL CIRCULATION; REMISSION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; VAGINA BLEEDING;

ADAM PROTEINS; ADULT; DIAGNOSIS, DIFFERENTIAL; ENZYME ACTIVATION; FEMALE; HUMANS; METALLOENDOPEPTIDASES; PLATELET TRANSFUSION; PURPURA, THROMBOTIC THROMBOCYTOPENIC; TREATMENT OUTCOME; UNCONSCIOUSNESS; UTERINE HEMORRHAGE;

EID: 4344714716     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Allford SL, Hunt BJ, Rose P et al. (2003) Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol 120:556-573
2. Assink K, Schiphorst R, Allford S et al. (2003) Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency. Kidney Int 63:1995-1999
3. Bennett CL, Kiss JE, Weinberg PD et al. (1998) Thrombotic thrombocytopenic purpura after stenting and ticlopidine. Lancet 352:1036-1037
4. Bennett CL, Connors JM, Carwile JM et al. (2000) Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med 342:1773-1777
5. Bianchi V, Robles R, Alberio L et al. (2002) Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura. Blood 100:710-713
6. Chemnitz J, Schulz A, Diehl V et al. (2001) Thrombotic-thrombocytopenic purpura (Moschcowitz syndrome). Med Klin 96:343-350
7. Chemnitz J, Draube A, Scheid C et al. (2002) Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab. Am J Hematol 71:105-108
8. Chung DW, Fujikawa K (2002) Processing of von Willebrand factor by ADAMTS-13. Biochemistry 41:11065-11070
9. Crowther MA, Heddle N, Hayward CP et al. (1996) Splenectomy done during hematologic remission to prevent relapse in patients with thrombotic thrombocytopenic purpura. Ann Intern Med 125:294-296
10. Dong JF, Moake JL, Bernardo A et al. (2003) Adamts-13 metalloprotease interacts with the endothelial cell-derivd ultra-large von Willebrand factor. J Biol Chem 32:29633-29639
11. George JN, Vesely SK (2003) Thrombotic thrombocytopenic purpura: from the bench to the bedside, but not yet to the community. Ann Intern Med 138:152-153
12. George JN, Sadler JE, Lammle B (2002) Platelets: thrombotic thrombocytopenic purpura. Hematology (Am Soc Hematol Educ Program) 315-334
13. Levy GG, Nichols WC, Lian EC et al. (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413:488-494
14. McCarthy U, Danielson CF, Miraglia C et al. (2003) Platelet transfusion and thrombotic thrombocytopenic purpura. Transfusion 43:829-830
15. Moake JE (2002) Thrombotic microangiopathies. N Engl J Med 347:589-600
16. Moschcowitz E (1924) Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc New York Pathol Soc 24:21-24
17. Ohlmann D, Hamann GF, Hassler M et al. (1996) Involvement of the central nervous system in hemolytic uremic syndrome/thrombotic thrombocytopenic purpura. Nervenarzt 67:880-882
18. Shumak KH, Rock GA, Nair RC (1995) Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Canadian Apheresis Group. Ann Intern Med 122:569-572
19. Torok TJ, Holman RC, Chorba TL (1995) Increasing mortality from thrombotic thrombocytopenic purpura in the United States - analysis of national mortality data, 1968-1991. Am J Hematol 50:84-90
20. Tsai HM (2002) Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. J Mol Med 80:639-647
21. Tsai HM, Lian EC (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339:1585-94
22. Tsai HM, Shulman K (2003) Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura. Eur J Haematol 70:183-185
23. Vesely SK, George JN, Lammle B et al. (2003) ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 102:60-68
24. Veyradier A, Obert B, Houllier A et al. (2001) Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood 98:1765-72